FDALiveFDALive.com

The World's Leading Source for FDA Broadcasting

POST Products

Our AdComm Transcripts service provides you a documentation of the meeting within 3-5 business days after the proceedings.

In order to expedite the service it is important to request this service in advance. The FDA provides transcripts of meetings for free 4-8 weeks after a meeting. Our service is for those that need this text media quickly.

Upcoming Meetings

Meeting OptionsMeeting OptionsMeeting OptionsMeeting OptionsMeeting OptionsOncologic Drugs Advisory Committee

Meeting Date: 2/9/21-2/9/21

.

Meeting Details:

The committee will discuss supplemental biologics license application (sBLA) 125514/s-089, for KEYTRUDA (pembrolizumab), submitted by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. The proposed indication (use) for this product is for the treatment of patients with high-risk, early-stage triple-negative breast cancer, in combination with chemotherapy as neoadjuvant treatment, then as a single agent as adjuvant treatment after surgery. The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform.

 

       
Location: Please note that due to the impact of this COVID-19 pandemic, all meeting participants will be joining this advisory committee meeting via an online teleconferencing platform. Related News Links: Not Available
Time: 10:00AM-2:00PM    
Materials:
   
       

View Meeting Details / News

Recent Meetings

Past Meetings

Below is a listing of all committees. Select a committee to display all meetings available for that committee.

Live Meetings

There are no Live Broadcasts available at this time.